|
Nano-X Imaging Ltd. (NNOX) DCF-Bewertung
IL | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Nano-X Imaging Ltd. (NNOX) Bundle
Vereinfachen Sie die Bewertung der Nano-X Imaging Ltd. (NNOX) mit diesem anpassbaren DCF-Taschenrechner! Mit Real Nano-X Imaging Ltd. (NNOX) Financials und einstellbaren Prognoseeingaben können Sie Szenarien testen und die beizulegende Zeit des Nano-X Imaging Ltd. (NNOX) in Minuten aufdecken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | 1.3 | 8.6 | 9.9 | 12.8 | 16.4 | 21.2 | 27.3 | 35.2 |
| Revenue Growth, % | 0 | 0 | 0 | 557.82 | 15.47 | 28.87 | 28.87 | 28.87 | 28.87 | 28.87 |
| EBITDA | -22.5 | -43.6 | -59.3 | -75.7 | -47.7 | -2.6 | -3.3 | -4.2 | -5.5 | -7.0 |
| EBITDA, % | 100 | 100 | -4544.94 | -882.44 | -481.5 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .1 | .2 | 2.3 | 11.5 | 11.8 | 12.8 | 16.4 | 21.2 | 27.3 | 35.2 |
| Depreciation, % | 100 | 100 | 175.77 | 134.2 | 119.23 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -22.6 | -43.8 | -61.6 | -87.2 | -59.5 | -2.6 | -3.3 | -4.2 | -5.5 | -7.0 |
| EBIT, % | 100 | 100 | -4720.71 | -1016.65 | -600.74 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 8.1 | 213.5 | 88.7 | 77.6 | 82.4 | 12.8 | 16.4 | 21.2 | 27.3 | 35.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 1.1 | 1.0 | 1.5 | 7.8 | 10.1 | 13.0 | 16.8 | 21.6 |
| Account Receivables, % | 100 | 100 | 80.6 | 11.39 | 14.98 | 61.39 | 61.39 | 61.39 | 61.39 | 61.39 |
| Inventories | .0 | .0 | 3.1 | 2.4 | 2.4 | 9.0 | 11.6 | 14.9 | 19.2 | 24.8 |
| Inventories, % | 100 | 100 | 239.95 | 28.14 | 23.79 | 70.39 | 70.39 | 70.39 | 70.39 | 70.39 |
| Accounts Payable | .5 | .4 | 3.1 | 3.6 | 3.3 | 9.6 | 12.4 | 15.9 | 20.5 | 26.4 |
| Accounts Payable, % | 100 | 100 | 240.34 | 42.19 | 33.35 | 75.11 | 75.11 | 75.11 | 75.11 | 75.11 |
| Capital Expenditure | -.1 | -13.9 | -23.2 | -7.2 | -3.3 | -5.5 | -7.1 | -9.2 | -11.9 | -15.3 |
| Capital Expenditure, % | 100 | 100 | -1775.92 | -83.6 | -33.35 | -43.39 | -43.39 | -43.39 | -43.39 | -43.39 |
| Tax Rate, % | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 | 0.55469 |
| EBITAT | -22.6 | -43.5 | -61.5 | -84.3 | -59.2 | -2.5 | -3.3 | -4.2 | -5.4 | -7.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -22.2 | -57.3 | -83.9 | -78.6 | -51.4 | -2.0 | 4.0 | 5.1 | 6.6 | 8.5 |
| WACC, % | 13.04 | 13.04 | 13.04 | 13.03 | 13.04 | 13.04 | 13.04 | 13.04 | 13.04 | 13.04 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 13.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 9 | |||||||||
| Terminal Value | 78 | |||||||||
| Present Terminal Value | 43 | |||||||||
| Enterprise Value | 56 | |||||||||
| Net Debt | -48 | |||||||||
| Equity Value | 104 | |||||||||
| Diluted Shares Outstanding, MM | 56 | |||||||||
| Equity Value Per Share | 1.84 |
What You Will Get
- Real NNOX Financial Data: Pre-filled with Nano-X Imaging Ltd.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Nano-X Imaging Ltd.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life NNOX Financials: Pre-filled historical and projected data for Nano-X Imaging Ltd.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Nano-X's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Nano-X's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine Nano-X Imaging Ltd.'s pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the results and utilize the findings for your investment strategies.
Why Choose Nano-X Imaging Ltd. (NNOX) Solutions?
- Streamline Processes: Our technology eliminates the need for complex imaging setups – it's ready for immediate use.
- Enhance Precision: Advanced imaging techniques ensure high-quality results with minimal errors.
- Fully Adaptable: Customize our imaging solutions to meet your specific diagnostic needs.
- User-Friendly: Intuitive interfaces and clear visuals make it simple to interpret imaging results.
- Endorsed by Professionals: Trusted by leading experts in the medical imaging field for its reliability and effectiveness.
Who Should Use This Product?
- Investors: Evaluate Nano-X Imaging Ltd. (NNOX) before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
- Startup Founders: Gain insights into how innovative tech companies like Nano-X are valued.
- Consultants: Provide comprehensive valuation analyses for clients in the healthcare sector.
- Students and Educators: Utilize real-time data to learn and teach valuation strategies.
What the Template Contains
- Pre-Filled DCF Model: Nano-X Imaging Ltd.'s (NNOX) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Nano-X Imaging Ltd.'s (NNOX) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.